Guardanthealth Eclipse Blood Test

Listing Websites about Guardanthealth Eclipse Blood Test

Filter Type:

Guardant Health announces positive results from pivotal ECLIPSE …

(7 days ago) Web- The test demonstrated 83% sensitivity for the detection of colorectal cancer with specificity of 90% - Results pave the way for first potential FDA-approved and …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/default.aspx

Category:  Cancer Show Health

A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening

(1 days ago) WebThe ECLIPSE (Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode) study was designed to evaluate the performance of the cfDNA …

https://www.nejm.org/doi/full/10.1056/NEJMoa2304714

Category:  Health Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(9 days ago) WebECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://www.businesswire.com/news/home/20221215006055/en/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer

Category:  Health Show Health

Guardant Health Initiates ECLIPSE Pivotal Study for its LUNAR-2 …

(2 days ago) WebGuardant Health, Inc. has initiated the ECLIPSE trial, a 10,000-patient registrational study to evaluate the performance of its LUNAR-2 blood test to detect colorectal cancer (CRC) …

https://www.guardanthealthamea.com/guardant-health-initiates-eclipse-pivotal-study-for-its-lunar-2-blood-test-for-colorectal-cancer-screening/

Category:  Cancer Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(4 days ago) WebThe test demonstrated 83% sensitivity for the detection of colorectal cancer with specificity of 90%

https://portal-local.guardanthealth.com/2022/12/15/guardant-health-announces-positive-results-from-pivotal-eclipse-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/

Category:  Cancer Show Health

FAQs Guardant Health Blood-Based Screening

(7 days ago) WebThe ECLIPSE clinical study, published in the New England Journal of Medicine, was a large-scale colorectal cancer screening study that evaluated the performance of Shield, …

https://bloodbasedscreening.com/faqs/

Category:  Cancer,  Medicine Show Health

Guardant Health to present real-world data supporting - BioSpace

(2 days ago) WebGuardant Health unveiled initial results from the ECLIPSE study validating the performance of the Shield test at the 2023 DDW meeting. The data served as the basis …

https://www.biospace.com/article/releases/guardant-health-to-present-real-world-data-supporting-performance-of-shield-blood-test-for-colorectal-cancer-screening-at-2024-digestive-disease-week/

Category:  Health Show Health

Home Guardant Health Blood-Based Screening

(2 days ago) WebGuardant Health has advanced our technology to include screening for early CRC detection 5,9. We are dedicated to supporting patients with cancer across the continuum of care. …

https://bloodbasedscreening.com/

Category:  Cancer Show Health

Guardant Health ECLIPSE Study Data Demonstrating Efficacy of …

(Just Now) WebECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://finance.yahoo.com/news/guardant-health-eclipse-study-data-210000399.html

Category:  Health Show Health

Guardant Health ECLIPSE Study Data Demonstrating Efficacy

(3 days ago) WebECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://www.morningstar.com/news/business-wire/20240313547689/guardant-health-eclipse-study-data-demonstrating-efficacy-of-shield-blood-based-test-for-colorectal-cancer-screening-to-be-published-in-the-new-england-journal-of-medicine

Category:  Health Show Health

Guardant Health to present real-world data supporting - Nasdaq

(Just Now) WebGuardant Health unveiled initial results from the ECLIPSE study validating the performance of the Shield test at the 2023 DDW meeting. The data served as the basis …

https://www.nasdaq.com/press-release/guardant-health-to-present-real-world-data-supporting-performance-of-shieldtm-blood

Category:  Health Show Health

Guardant Health to present real-world data supporting …

(Just Now) WebGuardant Health unveiled initial results from the ECLIPSE study validating the performance of the Shield test at the 2023 DDW meeting. The data served as the basis …

https://finance.yahoo.com/news/guardant-health-present-real-world-120500882.html

Category:  Health Show Health

Guardant Health Reaches Target Enrollment of 12,750 Patients in …

(7 days ago) WebGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it has reached its target enrollment of 12,750 patients in ECLIPSE …

https://exchange.guardanthealth.com/2021/12/17/guardant-health-reaches-target-enrollment-of-12750-patients-in-eclipse-pivotal-study-for-its-lunar-2-blood-test-to-detect-colorectal-cancer/

Category:  Health Show Health

Blood-Based DNA Test Shows Sensitivity of 83% for Colorectal …

(5 days ago) WebA new cell-free DNA blood based screening test demonstrated sensitivity of 83% for colorectal cancer (CRC), 90% specificity for advanced neoplasia, and 13% …

https://www.patientcareonline.com/view/blood-based-dna-test-shows-sensitivity-of-83-for-colorectal-cancer

Category:  Cancer Show Health

2024-05-16 NDAQ:GH Press Release Guardant Health Inc

(2 days ago) WebGuardant Health unveiled initial results from the ECLIPSE study validating the performance of the Shield test at the 2023 DDW meeting. The data served as the basis …

https://stockhouse.com/news/press-releases/2024/05/16/guardant-health-to-present-real-world-data-supporting-performance-of-shield-tm

Category:  Health Show Health

Guardant preps for FDA review of colorectal cancer blood test

(9 days ago) WebGuardant Health preps for FDA advisory panel review of its blood-based colorectal cancer screening test. Technically, Shield has been available to the public …

https://www.fiercebiotech.com/medtech/guardant-health-preps-fda-advisory-panel-review-its-blood-based-colorectal-cancer-screening

Category:  Cancer Show Health

Guardant Health to present real-world data supporting …

(9 days ago) WebGuardant Health unveiled initial results from the ECLIPSE study validating the performance of the Shield test at the 2023 DDW meeting. The data served as the basis …

https://markets.financialcontent.com/stocks/article/bizwire-2024-5-16-guardant-health-to-present-real-world-data-supporting-performance-of-shield-blood-test-for-colorectal-cancer-screening-at-2024-digestive-disease-week

Category:  Health Show Health

Guardant Health to present real-world data supporting

(1 days ago) WebAbstract. Session. Title. May 20, 2024, 12:30 – 1:30 p.m. ET # Mo1026 Poster Session: 8000 Integration of a blood-based colorectal cancer screening test into routine …

https://www.morningstar.com/news/business-wire/20240516838593/guardant-health-to-present-real-world-data-supporting-performance-of-shield-blood-test-for-colorectal-cancer-screening-at-2024-digestive-disease-week

Category:  Cancer Show Health

Guardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Call …

(6 days ago) WebGH ‎ +4.12% ‎. Guardant Health, Inc. (NASDAQ: GH) Q1 2024 Earnings Call Transcript May 10, 2024. Guardant Health, Inc. isn't one of the 30 most popular stocks among hedge …

https://www.msn.com/en-us/money/companies/guardant-health-inc-nasdaq-gh-q1-2024-earnings-call-transcript/ar-BB1mjnP3

Category:  Health Show Health

Filter Type: